Ultrasonix Medical Corporation has received CE certification
for its SonixGPS technology for Regional Anesthesia and Vascular Access, which will
be immediately available in all countries that are part of the European Community.
First approved for use in Canada,
the SonixGPS
technology has been used in hospitals in British Columbia
and Ontario since
October 2011. Clinical studies have proven the accuracy and clinical benefits of
using the new technology for guidance procedures such as nerve blocks for regional
anesthesia, and pain management and vascular access procedures which deliver medications
into a patient’s bloodstream.
“We’ve been using this technology routinely in the perioperative
setting and in the operating room,” said Dr. Brian Pollard. “SonixGPS has made a
difference for novices and advanced practitioners in reducing the time it takes
and the number of needle passes required to reach the desired end point.”
SonixGPS helps clearly predict and see the needle’s trajectory
during invasive procedures. Unlike other guidance technology, SonixGPS enables clinicians
to position the transducer in the ideal location to see the target and to select
a needle direction and angle that is safest and most comfortable for the patient.
It always shows the predicted trajectory and true path of the needle in real time.
Needle adjustments are reflected instantly on the display.
“We believe our needle guidance technology has the potential
to revolutionize the way many needle procedures are performed,” said Laurent Pelissier,
Founder and Chief Executive Officer of Ultrasonix. “Even though some of these procedures
can be done relatively easily by experienced physicians, there is always the potential
for major complications due to variations in patient anatomy. SonixGPS is proving
to be an excellent teaching tool for new physicians and it assists with complex
procedures.”
The SonixGPS is available on the SonixTouch, SonixTablet and
SonixMDP ultrasound systems. Ultrasonix will be demonstrating the new technology
at the Euroanesthesia conference in Paris France,
June 9-11, 2012.
About Ultrasonix
Ultrasonix develops and manufactures diagnostic ultrasound imaging systems with
customizable touch screens to simplify workflows. The company’s systems are built
on an open software platform that enables remote service and easy updates to keep
current with advancements in imaging technology. Founded in 2000, Ultrasonix is
a privately-held company headquartered in Richmond,
British Columbia, Canada.
www.ultrasonix.com/gps
